This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (24)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

DAVID L. KINSEY, MD; DARYL CARTER, MD; KARL P. KLASSEN, MD

AMA Arch Surg. 1964;89(2):389-392.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A very frequent complication of advancing lung and breast cancer is pleural metastases, resulting in the formation of an effusion. If the effusion remains unchecked, it is not uncommon for the patient to die of pulmonary insufficiency. Although a malignant effusion usually portends a poor prognosis, the marked palliation that is achieved with control of the effusion justifies an aggressive approach to the problem.

Various methods have been used in an effort to control malignant pleural effusion.⁶ All have had as their objectives removal of the fluid, reexpansion of the lung, and obliteration of the pleural space so that further fluid accumulation is impossible. Thoracentesis, alone or in combination with either intracavitary chemotherapy or various vesicants, has failed to give permanent control in the majority of patients. It is nearly impossible to remove all the pleural fluid and obtain full lung expansion with needle aspiration. As a result, pneumothorax, . . . [Full Text PDF of this Article]

Author Affiliations
COLUMBUS, OHIO

Advanced Clinical Fellow, American Cancer Society (Dr. Kinsey).; From the Department of Surgery, The Ohio State University Hospitals.

Footnotes
Read before the 21st Annual Meeting of the Central Surgical Association, Rochester, Minn, Feb 27-29, 1964.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?